Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Helix BioPharma

  • Helix Establishes Polish Subsidiary for Cancer Drug Development
    Helix BioPharma has established a subsidiary in Poland, Helix Polska, to facilitate and support ongoing clinical oncology research at leading institutions in the country. The ...
    8-29-2013
  • People in the News
    ... Christopher S. Destro joined Atossa Genetics as vp of sales and marketing...Helix BioPharma named John A. Rogers to its board of directors. Send your People Announcements to ...
    1-15-2013
  • GEN Reports on Growing Interest in Antibody-Drug Conjugates
    Helix Biopharma is developing L-DOS47 against non-small-cell lung cancer. It uses the plant enzyme urease to hydrolyze urea, thereby generating ammonia at the site of the tumor ...
    12-10-2012
  • Pharmascience Snaps Up Rivex in $8.5M Deal
    Helix BioPharma is selling its Rivex Pharma division to Pharmascience for up to $8.5 million cash, the companies said today. Helix said it will use the proceeds to fund ongoing R&D ...
    12-10-2012
  • Cancer Research Firms Eye ADCs to Extend Portfolios
    Helix Biopharma is developing L-DOS47 against non-small-cell lung cancer. It uses the plant enzyme urease to hydrolyze urea, thereby generating ammonia at the site of the tumor ...
    12-1-2012
  • Helix Secures $9.5M to Advance Clinical Trials
    Helix BioPharma closed a private placement with net proceeds of approximately $9.5 million. The money will be used primarily to support the company's clinical trial initiatives. ...
    8-9-2010
  • Firm's Pipeline Targeted at HPV and Cancer
    Helix BioPharma Utilizes Biphasix and DOS47 Technology to Advance Cancer-Related Drugs The overall goal at Helix BioPharma is to develop treatments for cancer and precancerous ...
    9-15-2008
  • BioVectra to Manufacture Helix' Lung Cancer Candidate
    Helix BioPharma signed an agreement with BioVectra to manufacture L-DOS47 bulk drug product for clinical testing in patients with adenocarcinoma of the lung. "BioVectra is a ...
    1-5-2007

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll